Filing
Spy
Filing
Spy
Home
About
AKBA — Akebia Therapeutics Inc - FilingSpy
AKBA
Akebia Therapeutics Inc
Biopharmaceutical company
CUSIP: 00972D105
Healthcare
US
2 holders
Ownership
Activity
Fundamentals
2019 Q4
6 of 11 quarters
Total Value
$159.44M
Total Shares
25.23M
Net Share Change
-4.90M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$123.69M
19.57M
1.4%
TRIM
-4.90M
(-20.0%)
Baupost Group LLC
$123.69M
19.57M shares
TRIM
-4.90M
(-20.0%)
Abrams Capital Management
$35.75M
5.66M
1.1%
Unchanged
Abrams Capital Management
$35.75M
5.66M shares
Unchanged